All articles by
Sports Data Labs announces Issuance of New U.S. Patent Covering its Novel Generative AI-Based Method for Creating Synthetic Data to Replace Missing and Outlier Data Values
Issuance of U.S. Patent No. 11,850,053 also covers a novel system and method for calculating accurate, real-time heart rate (HR) measurements from electrocardiogram (ECG)-based sensors
UnitedHealth to divest Brazilian health insurance business for $515m
José Seripieri Filho, the founder and former CEO of health insurance firm Qualicorp, will acquire UnitedHealth’s Brazilian health insurance business, including Amil Insurance, Amil Integrated Care, Amil Dental and Americas Hospitals in Brazil
Stuart Therapeutics reports FPFV in Phase 3 trial of Vezocolmitide to treat dry eye disease
The late-stage multi-centre, randomised, double-masked, placebo-controlled trial will evaluate the safety and effectiveness of ST-100 ophthalmic solution in patients with dry eye disease
Jiangsu Recbio reports positive results for adjuvanted recombinant shingles vaccine
According to an interim analysis, healthy individuals aged 40 years and above showed an overall favourable safety and tolerability profile for REC610 following two doses of the immunisation
HOC expands metaverse medical consultation and education platform
HOC will expand its metaverse platform to Kazakhstan, Colombia, and other Latin American countries in 2024, and introduce its CLOUD HOSPITAL and META-VERSITY in Colombia as part of a collaborative Feasibility Study
Bristol Myers Squibb to acquire Karuna Therapeutics for $14bn
Karuna is a biopharmaceutical firm focused on the discovery, development and delivery of transformative medicines for individuals with psychiatric and neurological conditions
Takeda gets China NMPA nod for Livtencity to treat certain CMV patients
The authorisation was based on the findings from the Phase 3 SOLSTICE trial in which Livtencity was found superior to conventional therapies at week eight, thus meeting the primary endpoint
Ocelot Bio gets FDA orphan drug status for OCE-205 to treat ascites
OCE-205 is a therapeutic peptide with a differentiated mechanism of action, designed to relieve portal hypertension while offering a capped maximal efficacy
Palatin Completes Sale of Vyleesi to Cosette Pharmaceuticals for up to $171m
Palatin’s focus is solely on its development and clinical pipeline based on the melanocortin receptor system
Terran Biosciences Receives FDA Clearance for NM-101, the industry’s first software for the analysis of neuromelanin-sensitive MRI
Currently, there is no other FDA-cleared software indicated for the analysis of neuromelanin MRI on the market, making Terran’s technology the world’s first